Following the acquisition of Biopas, the pharmaceutical company expands its operations to Latin America

Swixx BioPharma has acquired Laboratorio Biopas to expand its reach into Latin America.

Swixx BioPharma has acquired Laboratorio Biopas to expand its reach into Latin America.

The Swiss law firm Homburger advised the Latin American pharmaceutical company Laboratorios Biopas in connection with its acquisition by the commercial platform Swixx BioPharma. Under the agreement, Swixx BioPharma will acquire 100% of shares in the holding company Pharma Consulting Group, the holding company of Biopas.

The team advising on the sale includes corporate and M&A partners Andreas Müller and Anna Peter, corporate and M&A associates Hans Glent Abildgaard and Harun Cetin, finance and investment products partner Stefan Bindschedler, tax partner Reto Heuberger and tax advisor Philippe Weber.

Swixx BioPharma provides access to innovative medicines around the world and with its latest acquisition plans to expand into Latin America.

As a result of the transaction, which is expected to be finalized later this year, the founders of Biopas will become shareholders of Swixx BioPharma, and the operations in Latin America will continue under the Biopas name.

Biopas CEO and co-founder Pascal Forget stated: “We are excited to join the Swixx BioPharma group and contribute to the development of a broad and distinctive cross-regional platform. We strongly believe that by joining forces with Swixx, we will be better positioned to fulfill our mission of bringing innovative medicines to the people of Latin America. Both companies have similar missions and business models, and their combination will generate significant value for our partners and our patients. We will continue to provide effective solutions and unlock access in the region, while cultivating long-term relationships with all Biopas stakeholders.”

Jean-Michael Lespinasse, CEO of Swixx BioPharma, added: “We look forward to working closely with the wonderful, dedicated professionals that Biopas has attracted across Latam. We will work with passion, with respect for the staff and the entrepreneurial culture of Biopas, to bring both companies together and thus create something greater than the sum of their two parts.